BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 21209106)

  • 1. Kaposi's sarcoma-associated herpesvirus-induced angiogenin plays roles in latency via the phospholipase C gamma pathway: blocking angiogenin inhibits latent gene expression and induces the lytic cycle.
    Sadagopan S; Valiya Veettil M; Paudel N; Bottero V; Chandran B
    J Virol; 2011 Mar; 85(6):2666-85. PubMed ID: 21209106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen and angiogenin interact with common host proteins, including annexin A2, which is essential for survival of latently infected cells.
    Paudel N; Sadagopan S; Balasubramanian S; Chandran B
    J Virol; 2012 Feb; 86(3):1589-607. PubMed ID: 22130534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with multifunctional angiogenin to utilize its antiapoptotic functions.
    Paudel N; Sadagopan S; Chakraborty S; Sarek G; Ojala PM; Chandran B
    J Virol; 2012 Jun; 86(11):5974-91. PubMed ID: 22438557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaposi's sarcoma-associated herpesvirus upregulates angiogenin during infection of human dermal microvascular endothelial cells, which induces 45S rRNA synthesis, antiapoptosis, cell proliferation, migration, and angiogenesis.
    Sadagopan S; Sharma-Walia N; Veettil MV; Bottero V; Levine R; Vart RJ; Chandran B
    J Virol; 2009 Apr; 83(7):3342-64. PubMed ID: 19158252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma tumor formation in NOD/SCID mice is inhibited by neomycin and neamine blocking angiogenin's nuclear translocation.
    Bottero V; Sadagopan S; Johnson KE; Dutta S; Veettil MV; Chandran B
    J Virol; 2013 Nov; 87(21):11806-20. PubMed ID: 23986578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear Innate Immune DNA Sensor IFI16 Is Degraded during Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus (KSHV): Role of IFI16 in Maintenance of KSHV Latency.
    Roy A; Dutta D; Iqbal J; Pisano G; Gjyshi O; Ansari MA; Kumar B; Chandran B
    J Virol; 2016 Oct; 90(19):8822-41. PubMed ID: 27466416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
    Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
    J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression.
    Sharma-Walia N; Raghu H; Sadagopan S; Sivakumar R; Veettil MV; Naranatt PP; Smith MM; Chandran B
    J Virol; 2006 Jul; 80(13):6534-52. PubMed ID: 16775340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting KSHV/HHV-8 latency with COX-2 selective inhibitor nimesulide: a potential chemotherapeutic modality for primary effusion lymphoma.
    Paul AG; Sharma-Walia N; Chandran B
    PLoS One; 2011; 6(9):e24379. PubMed ID: 21980345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression.
    Krishnan HH; Naranatt PP; Smith MS; Zeng L; Bloomer C; Chandran B
    J Virol; 2004 Apr; 78(7):3601-20. PubMed ID: 15016882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutual inhibition between Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus lytic replication initiators in dually-infected primary effusion lymphoma.
    Jiang Y; Xu D; Zhao Y; Zhang L
    PLoS One; 2008 Feb; 3(2):e1569. PubMed ID: 18253508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
    Ye J; Gradoville L; Daigle D; Miller G
    J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kaposi's sarcoma-associated herpesvirus induces the ATM and H2AX DNA damage response early during de novo infection of primary endothelial cells, which play roles in latency establishment.
    Singh VV; Dutta D; Ansari MA; Dutta S; Chandran B
    J Virol; 2014 Mar; 88(5):2821-34. PubMed ID: 24352470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Kaposi's sarcoma-associated herpesvirus (KSHV)-induced 5-lipoxygenase-leukotriene B4 cascade plays key roles in KSHV latency, monocyte recruitment, and lipogenesis.
    Sharma-Walia N; Chandran K; Patel K; Veettil MV; Marginean A
    J Virol; 2014 Feb; 88(4):2131-56. PubMed ID: 24335295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells.
    Purushothaman P; Thakker S; Verma SC
    J Virol; 2015 Mar; 89(6):3093-111. PubMed ID: 25552714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kaposi's sarcoma-associated herpesvirus latency in endothelial and B cells activates gamma interferon-inducible protein 16-mediated inflammasomes.
    Singh VV; Kerur N; Bottero V; Dutta S; Chakraborty S; Ansari MA; Paudel N; Chikoti L; Chandran B
    J Virol; 2013 Apr; 87(8):4417-31. PubMed ID: 23388709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaposi's Sarcoma-Associated Herpesvirus Infection Induces the Expression of Neuroendocrine Genes in Endothelial Cells.
    Valiya Veettil M; Krishna G; Roy A; Ghosh A; Dutta D; Kumar B; Chakraborty S; Anju TR; Sharma-Walia N; Chandran B
    J Virol; 2020 Mar; 94(8):. PubMed ID: 31969437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
    Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
    mBio; 2018 May; 9(3):. PubMed ID: 29739902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.
    Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection.
    Sharma-Walia N; Krishnan HH; Naranatt PP; Zeng L; Smith MS; Chandran B
    J Virol; 2005 Aug; 79(16):10308-29. PubMed ID: 16051824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.